Xcout Intel
Bloom Science
Bloom Science, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on developing novel central nervous system therapies for neurological and metabolic disorders.
Subscribe to see Bloom Science’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Bloom Science at a glance
Bloom Science is a biotechnology company headquartered in United States. It has raised at least $12.1M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $12M in December 2021. Xcout tracks 6 named people at Bloom Science, including Paolo Baroldi, PhD, MD (CHIEF MEDICAL OFFICER).
Bloom Science leadership
- Paolo Baroldi, PhD, MDCHIEF MEDICAL OFFICER
- Christopher Reyes, PhDCEO, FOUNDER, DIRECTOR
- Louis Licamele, PhDCHIEF DEVELOPMENT OFFICER, FOUNDING TEAM, EVP OF CLINICAL & DATA SCIENCE
- Grace E. ColonBOARD CHAIR
- Felix Frueh, PhDDIRECTOR
- Felix von CoerperDIRECTOR
Bloom Science funding rounds
At least $12.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $12M | 5 named | |
| — | $95,000 | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Bloom Science competitors
A few of Bloom Science's closest competitors — see the full list of competitors and alternatives →
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Recognify Life Sciences is a clinical-stage biotechnology company located in California, focusing on developing treatments for cognitive impairment associated with central nervous system disorders.
Eumentis Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to developing novel therapies for serious neuropsychiatric conditions.
Bloom Labs Bio Inc. specializes in the development and manufacturing of biologics, biosimilars, recombinant proteins, monoclonal antibodies, prebiotics, and probiotics. Utilizing modern biotechnology platforms and advanced infrastructure, the company serves the pharmaceutical and life sciences sectors with therapeutic and health and wellness solutions.
Syremis Therapeutics Ltd. is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, dedicated to developing novel drug pipeline medicines targeted at treating diseases of the nervous system and mental health disorders.
Neumora Therapeutics is a clinical-stage biopharmaceutical company developing precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. It uses neuroscience, data science, and biomarkers to identify and advance treatments for patients with these conditions.
Get Bloom Science's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Bloom Science in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access